Role of Sildenafil for Fontan Associated Liver Disease (SiFALD) Study
Status:
Completed
Trial end date:
2019-06-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if the medication, sildenafil (also known as
Revatio), can slow or stop the progression of liver disease in patients who previously had a
Fontan operation.